文献速递神经肿瘤

恶性乳腺癌女性患者后续脑膜瘤风险增加

Increased Risk of Subsequent Meningioma Among Women with Malignant Breast Cancer.
PubMed 文献 · World Neurosurg · 2020-04-13

该研究利用SEER数据库18个登记处2004至2016年诊断为乳腺癌的564,516例女性,分析其后续脑膜瘤的标准化发病比。结果显示乳腺癌女性脑膜瘤风险较一般人群升高26%(SIR 1.26,95%CI 1.19-1.33,P<0.05),18至49岁及IV期患者风险更高。

要点

  • 乳腺癌女性后续脑膜瘤风险较一般人群升高26%(SIR 1.26,95%CI 1.19-1.33,P<0.05)。
  • 18至49岁患者脑膜瘤风险更高(SIR 2.16,95%CI 1.78-2.61,P<0.05)。
  • IV期患者脑膜瘤风险更高(SIR 2.39,95%CI 1.71-3.25,P<0.05)。

核心结论

  • 研究证实乳腺癌与脑膜瘤之间的已知关联,乳腺癌女性脑膜瘤风险升高26%,年轻患者及更具侵袭性疾病者风险高于预期。

研究设计与样本

  • 利用SEER数据库18个登记处,纳入2004至2016年以乳腺癌为首发肿瘤的女性564,516例,分析后续脑膜瘤风险,以标准化发病比(SIR)表示并按社会人口学和临床病理亚组分析。

主要发现

  • 整个队列脑膜瘤风险较一般人群升高26%(SIR 1.26,95%CI 1.19-1.33,P<0.05)。
  • 18至49岁患者脑膜瘤风险较一般人群升高(SIR 2.16,95%CI 1.78-2.61,P<0.05)。
  • IV期患者脑膜瘤风险较一般人群升高(SIR 2.39,95%CI 1.71-3.25,P<0.05)。
  • 激素受体表达及治疗方式亚组的风险与一般人群相似。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: Despite the increasing evidence of the association between breast cancer and meningioma in women, the relationship between these tumors remains improperly examined. In this study, we aim to identify the sociodemographic and clinicopathologic features of women with breast cancer associated with a higher risk of developing a meningioma. METHODS: The SEER (Surveillance Epidemiology and End Results) database (18 registries) was used to identify women with breast cancer as their first neoplasm. The risk of subsequent meningioma was reported as the standardized incidence ratio (SIR) and was analyzed by sociodemographic and clinicopathologic subgroups. Results are given as SIR (95% confidence interval [CI]). RESULTS: A total of 564,516 women diagnosed with breast cancer between 2004 and 2016 were included for analysis. A 26% increased risk of meningioma development (SIR, 1.26; 95% CI, 1.19-1.33; P < 0.05) was found in the cohort compared with the general population. Patients aged between 18 and 49 years (SIR, 2.16; 95% CI, 1.78-2.61; P < 0.05) and those with a more advanced tumor stage (stage IV; SIR, 2.39; 95% CI, 1.71-3.25; P < 0.05) were at a higher risk. Hormone receptor expression and treatment modality subgroups were at a similar risk compared with the general population. CONCLUSIONS: Our study corroborated the known association between these tumors and found a 26% risk of meningioma development in women with breast cancer, with younger patients and those with a more aggressive disease having a higher than expected risk.

来源:World Neurosurg,查看原文。版权归原作者所有。

引用

  1. Lopez-Rivera V, Zhu P, Dono A, et al. Increased Risk of Subsequent Meningioma Among Women with Malignant Breast Cancer. World Neurosurg. 2020. PMID: 32298823. doi:10.1016/j.wneu.2020.03.203

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。